SynBioBeta Speaker
Gleb Kuznetsov
Co-Founder and CEO
Manifold Bio
YEAR
25
May 2025, SynBioBeta
Keynote Speaker
Gleb Kuznetsov is co-founder and CEO of Manifold Bio, a biotechnology company aiming to revolutionize protein therapeutics discovery through novel measurement and design technologies. Gleb comes from an interdisciplinary technical background spanning computational and molecular biology. He completed a Ph. D. in the Harvard Biophysics program combining massively parallel capabilities of DNA sequencing, DNA synthesis, and machine learning technologies.
SynBioBeta 2025 - Keynote
Reprogramming Drug Delivery: How Synthetic Biology is Unlocking the Next Generation of Therapeutics
Synthetic biology is redefining drug delivery, enabling breakthroughs in precision, targeting, and bioavailability. But what does synthetic biology really mean in this space? This panel brings together a diverse group of entrepreneurs and pharmaceutical leaders to discuss how they integrate synthetic biology to overcome key delivery challenges. Panelists will also explore the strategic questions of building a drug delivery company: Should they develop their own therapeutics or partner with pharma? How do they avoid commoditization and create lasting value? Join us for a dynamic discussion at the intersection of science and strategy in next-generation drug delivery.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Other Speakers
Other Speakers
2026
Event Updates